Monday - April 20, 2026

Category Archives: Pharmaceuticals & Biotech

Pulmonary Hypertension associated Interstitial Lung Disease Market Size (7MM) was ~USD 3 Billion in 2025 and is projected to expand at a CAGR of 3.9% through 2036, estimates DelveInsight

DelveInsight’s “Pulmonary Hypertension associated Interstitial Lung Disease Market Insights, Epidemiology, and Market Forecast – 2036” report delivers an in-depth understanding of the Pulmonary Hypertension associated Interstitial Lung Disease, historical and forecasted epidemiology and the Pulmonary Hypertension associated Interstitial Lung Disease … Continue reading →

Familial Chylomicronemia Syndrome Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Familial Chylomicronemia Syndrome Pipeline Insights 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Familial Chylomicronemia Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Metastatic Colorectal Cancer Treatment Clinical Trial Pipeline Shows Potential with Active Contributions from 150+ Key Companies | DelveInsight

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2026” report provides comprehensive insights about 150+ companies and 180+ pipeline drugs in Metastatic Colorectal Cancer pipeline landscape. It covers the Metastatic Colorectal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Lupus Nephritis Clinical Trial Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Lupus Nephritis Pipeline Insight 2026” report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Lupus Nephritis pipeline landscape. It covers the Lupus Nephritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Endometriosis Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Endometriosis Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Endometriosis pipeline landscape. It covers the Endometriosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Endometriosis Pipeline therapeutics … Continue reading →

Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research

A renewed spotlight is forming around a group of small-cap healthcare companies as U.S. policy shifts toward accelerating research into psychedelic-based therapies for mental health disorders. Following a recent executive order aimed at expanding research pathways, companies below are drawing … Continue reading →

CRISPR Market Set to Reach $5.47 Billion by 2030 Amid Surge in Gene Editing Applications and Biotech Investments

CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030 According to MarketsandMarkets™, the CRISPR market is projected to grow from … Continue reading →

Insulin Delivery Devices Market to Reach $52.7 Billion by 2030 as Diabetes Burden and Innovation Accelerate Growth

Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) – Global Forecast to 2030 According to MarketsandMarkets™, the Insulin … Continue reading →

Multiple Sclerosis Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharma, Sanofi, RemeGen

The Key Multiple Sclerosis Companies in the market include – Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharmaceuticals, Sanofi, RemeGen, Gossamer Bio, 4D Pharma, HuniLife Biotechnology, Anokion, GSK plc, GeNeuro, Immunic Therapeutics, Sanofi, Hoffman-La-Roche, and others.   DelveInsight’s … Continue reading →